n,n-carbonyldiimidazole has been researched along with Breast Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abedin, MR; Aiardo, R; Barua, D; Barua, S; Powers, K | 1 |
| Ahmad, SAA; Kamarudin, MA; Lah, ZMANH; Zaini, MS | 1 |
2 other study(ies) available for n,n-carbonyldiimidazole and Breast Cancer
| Article | Year |
|---|---|
Antibody-drug nanoparticle induces synergistic treatment efficacies in HER2 positive breast cancer cells.
Topics: Antibodies; Antineoplastic Agents; Apoptosis; Biocompatible Materials; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Drug Delivery Systems; Drug Screening Assays, Antitumor; Female; Fluorescent Dyes; G2 Phase Cell Cycle Checkpoints; Humans; Imidazoles; Inhibitory Concentration 50; Lysine; Magnetic Resonance Spectroscopy; Microscopy, Electron, Scanning; Nanomedicine; Nanoparticles; Paclitaxel; Receptor, ErbB-2; Trastuzumab | 2021 |
An Electrochemical Sandwich Immunosensor for the Detection of HER2 using Antibody-Conjugated PbS Quantum Dot as a label.
Topics: Algorithms; Antibodies; Biomarkers, Tumor; Biosensing Techniques; Breast Neoplasms; Carbon; Electrochemical Techniques; Female; Humans; Imidazoles; Immunoassay; Lead; Limit of Detection; Linear Models; Mercury; Metal Nanoparticles; Nanomedicine; Nanostructures; Quantum Dots; Receptor, ErbB-2; Reproducibility of Results; Sulfides | 2019 |